AFP and hepatocellular carcinoma: The results of this study demonstrate that both AFP and PIVKA-II have independent diagnostic value in the detection of HCC among patients with chronic hepatitis B and C. Importantly, the combined use of these two biomarkers yielded superior predictive accuracy compared with either marker alone, consistently across both etiological cohorts.